ReviewJournal of pain research2017
Hemicrania continua: clinical review, diagnosis and management.
Review in Journal of pain research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 57 citations in OpenAlex.
- Third Occipital Nerve Block and Cooled Radiofrequency Ablation for Managing Hemicrania Continua: A Case Report.Cureus · 2025Article
- Hemicrania continua with rhinosinusitis: a case report.Korean journal of family medicine · 2025Article
- Feasibility of a High-Dose Inhaled Indomethacin Dry Powder with Dual Deposition for Pulmonary and Oral Delivery.Pharmaceutics · 2024Article
- Hemicrania Continua: An Update.Current pain and headache reports · 2023Review
- Secondary hemicrania continua-tic syndrome associated with fungal sphenoiditis: A case report.Clinical case reports · 2021Article
- Hemicrania continua associated with an unruptured anterior communicating artery aneurysm: first case report.The journal of headache and pain · 2021Article
- Temporary resolution of hemicrania continua following ipsilateral ear piercing.BMJ neurology open · 2021Article
- The Promising Effect of Nerve Decompression in Trigeminal Autonomic Cephalalgias: Report of Case Series.Frontiers in neurology · 2021Article
- Article
- Trigeminal autonomic cephalalgias presenting in a multidisciplinary tertiary orofacial pain clinic.The journal of headache and pain · 2019Article
- A case of remitting hemicrania continua with seasonal variation and clustering: a diagnostic confusion with cluster headache.BMJ case reports · 2019Article
- The Exacerbation of Hemicrania Continua Mimics Trigeminal Neuralgia.Internal medicine (Tokyo, Japan) · 2019Article
- Hemicrania Continua: a Clinical Perspective on Diagnosis and Management.Current neurology and neuroscience reports · 2018Review
- Hemicrania Continua.Annals of Indian Academy of Neurology · 2018Review
- Herpes zoster ophthalmicus evolving into headache characterised as hemicrania continua.BMJ case reports · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemicrania continua (HC) is an indomethacin-responsive primary headache disorder which is currently classified under the heading of trigeminal autonomic cephalalgias (TACs). It is a highly misdiagnosed and underreported primary headache. The pooled mean delay of diagnosis of HC is 8.0 ± 7.2 years. It is not rare. We noted more than 1000 cases in the literature. It represents 1.7% of total headache patients attending headache or neurology clinic. Just like other TACs, it is characterized by strictly unilateral pain in the trigeminal distribution, cranial autonomic features in the same area and agitation during exacerbations/attacks. It is different from other TACs in one aspect. While all other TACs are episodic, HC patients have continuous headaches with superimposed severe exacerbations. The central feature of HC is continuous background headache. However, the patients may be worried only for superimposed exacerbations. Focusing only on exacerbations and ignoring continuous background headache are the most important factors for the misdiagnosis of HC. A large number of patients may have migrainous features during exacerbation phase. Up to 70% patients may fulfill the diagnostic criteria for migraine during exacerbations. Besides migraine, its exacerbations can mimic a large number of other primary and secondary headaches. The other specific feature of HC is a remarkable response to indomethacin. However, a large number of patients develop side effects because of the long-term use of indomethacin. A few other medications may also be effective in a subset of patients with HC. Various surgical interventions have been suggested for patients who are intolerant to indomethacin. Several aspects of HC are still not defined. There is a great heterogeneity in types of patients or articles on the HC in the literature. Diagnostic criteria have been modified several times over the years. The current diagnostic criteria are too restrictive in some aspects. We suggest a more accommodating type of criteria for the appendix of International Classification of Headache Disorder (ICHD).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.